Meram Azzani1, April Camilla Roslani, Tin Tin Su. 1. Centre for Population Health (CePH), Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia, dr_memeazzani@yahoo.com.
Abstract
PURPOSE: The escalating health-care spending for cancer management has caused cancer patients to struggle further as a result of financial burden. This systematic review was carried out to investigate the prevalence of perceived financial hardship and associated factors among cancer patients and their families. METHODS: A systematic search for studies concerning the perception of financial burden among cancer patients and their families was conducted. Several electronic resources such as Medline, Elsevier (Science Direct), Web of Science, Embase, PubMed, CINAHL and Scopus (SciVerse) were searched. Additionally, manual search through indices citation was also thoroughly utilized. The main outcome of interest was the prevalence of perceived financial hardship among cancer patients and their families. Studies reported only the cost of cancer treatment and qualitative studies were excluded. Our search was limited to articles that were published from 2003 to 2013. RESULT: Ten studies were included in this review and with a majority originating from high-income countries. The prevalence of the financial burden perception was reported between 14.8 and 78.8 %. The most frequent and significant risk factor reported associated with the perception of financial difficulty was the households with low income. Discontinuation of treatment and poverty were conversely the important consequences of financial burden in cancer patients and their families. CONCLUSION: Evidently, cancer is a long-term illness that requires a high financial cost, and a significant number of cancer patients and families struggle with financial difficulty. Identifying such groups with a high risk of facing financial difficulty is a crucial measure to ensure safety nets are readily available for these targeted population.
PURPOSE: The escalating health-care spending for cancer management has caused cancerpatients to struggle further as a result of financial burden. This systematic review was carried out to investigate the prevalence of perceived financial hardship and associated factors among cancerpatients and their families. METHODS: A systematic search for studies concerning the perception of financial burden among cancerpatients and their families was conducted. Several electronic resources such as Medline, Elsevier (Science Direct), Web of Science, Embase, PubMed, CINAHL and Scopus (SciVerse) were searched. Additionally, manual search through indices citation was also thoroughly utilized. The main outcome of interest was the prevalence of perceived financial hardship among cancerpatients and their families. Studies reported only the cost of cancer treatment and qualitative studies were excluded. Our search was limited to articles that were published from 2003 to 2013. RESULT: Ten studies were included in this review and with a majority originating from high-income countries. The prevalence of the financial burden perception was reported between 14.8 and 78.8 %. The most frequent and significant risk factor reported associated with the perception of financial difficulty was the households with low income. Discontinuation of treatment and poverty were conversely the important consequences of financial burden in cancerpatients and their families. CONCLUSION: Evidently, cancer is a long-term illness that requires a high financial cost, and a significant number of cancerpatients and families struggle with financial difficulty. Identifying such groups with a high risk of facing financial difficulty is a crucial measure to ensure safety nets are readily available for these targeted population.
Authors: John A Heath; R Mario Lintuuran; Gemma Rigguto; Nicole Tokatlian; Nicole Tikotlian; Maria McCarthy Journal: Pediatr Hematol Oncol Date: 2006 Jul-Aug Impact factor: 1.969
Authors: Mark D Huffman; Krishna D Rao; Andres Pichon-Riviere; Dong Zhao; S Harikrishnan; Kaushik Ramaiya; V S Ajay; Shifalika Goenka; Juan I Calcagno; Joaquín E Caporale; Shaoli Niu; Yan Li; Jing Liu; K R Thankappan; Meena Daivadanam; Jan van Esch; Adrianna Murphy; Andrew E Moran; Thomas A Gaziano; Marc Suhrcke; K Srinath Reddy; Stephen Leeder; Dorairaj Prabhakaran Journal: PLoS One Date: 2011-06-14 Impact factor: 3.240
Authors: Florence K L Tangka; Sujha Subramanian; Madeleine Jones; Patrick Edwards; Timothy Flanigan; Yevgeniya Kaganova; Kevin W Smith; Cheryll C Thomas; Nikki A Hawkins; Juan Rodriguez; Temeika Fairley; Gery P Guy Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-03 Impact factor: 4.254
Authors: Susanne Singer; Julia Roick; Jürgen Meixensberger; Franziska Schiefke; Susanne Briest; Andreas Dietz; Kirsten Papsdorf; Joachim Mössner; Thomas Berg; Jens-Uwe Stolzenburg; Dietger Niederwieser; Annette Keller; Anette Kersting; Helge Danker Journal: Support Care Cancer Date: 2017-12-21 Impact factor: 3.603
Authors: Robin L Whitney; Janice F Bell; Sarah C Reed; Rebecca Lash; Richard J Bold; Katherine K Kim; Andra Davis; David Copenhaver; Jill G Joseph Journal: J Cancer Surviv Date: 2015-07-19 Impact factor: 4.442